http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2608185-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8925b769d645f9ff06af9f4b189f6a99 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5015 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5026 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5047 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4439 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4184 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-62 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4184 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4439 |
| filingDate | 2006-05-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_11ca22e4e7c6556296d277a9c8069860 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_778e3f534499f83221fb1dd42137b13c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eb2c7ee773ba75ba32ab5a03ba07b6ef http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c2d8527e752416ebbc946912a06e3a08 |
| publicationDate | 2006-11-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CA-2608185-A1 |
| titleOfInvention | Oral medicament based on a proton pump inhibitors |
| abstract | The invention relates to oral medicaments with modified release of PPI, more particularly useful for the prevention and treatment of gastrointestinal. The object of the invention is to provide a new PPI-based oral medicinal product ideally presenting all or some of the following characteristics: a) To quickly relieve the patient with elevation of gastric pH, after oral administration of the drug, b) Accelerate healing of patients by maintaining this elevation of gastric pH, the most for a long time after oral administration of the drug, and in particular overnight, c) Improve treatment compliance and comfort patient by a single daily intake. To achieve this goal, microcapsules of the invention, preferably non-enteric, are constituted of microparticles of IPP coated with ethylcellulose, a copolymer ammonio-methacrylate (Eudragit ~ RL 100), polyvinylpyrrolidone, castor oil and polyoxyethylenated hydrogenated castor oil (40). This drug is designed so that after ingestion for a administration in a single daily dose, it allows to maintain, from the first day of treatment, a mean gastric pH between 0 and 24h, greater or equal to the average gastric pH between 0 and 24h obtained with an oral medication immediate-release enteric reference * administered in the same conditions. The invention also relates to these microcapsules per se. |
| priorityDate | 2005-05-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 173.